| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.9 |